CURRICULUM VITAE
Guan Chen MD, PhD
Guan Chen MD, PhD
Professor
Department of Pharmacology and Toxicology
Department of Pharmacology and Toxicology
OFFICE ADDRESS: |
Medical Education Building |
8701 Watertown Plank Rd |
Milwaukee, WI 53226 |
Phone: 414-456-8636 |
Email: gchen@mcw.edu |
EDUCATION: |
01/1982 - Present MD, Bengbu Medical College, Anhui, P.R. China |
1982 MD, Bengbu Medical College, Anhui, P.R. China |
01/1985 - Present MS, Sun Yat-Sen University, GuangZhou, P.R. China |
1985 MS, Sun Yat-Sen University, GuangZhou, P.R. China |
01/1990 - Present PhD, University of Heidelberg, Heidelberg, Germany |
1990 PhD, University of Heidelberg, Heidelberg, Germany |
01/1995 - Present Post Doctorate, Dana-Farber Cancer Institute, Harvard Medical School, Boston |
1995 Post Doctorate, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA |
FACULTY APPOINTMENTS: |
01/1986 - 12/1987 Research Associate, Cancer Institute, Sun Yat-Sen University, GuangZhou, P.R. China |
1986 - 1987 Research Associate, Cancer Institute, Sun Yat-Sen University, GuangZhou, P.R. China |
01/1988 - Present Lecturer, Cancer Institute, Sun Yat-Sen University, GuangZhou, P.R. China |
01/1988 - 12/1992 Guest Scientist, Inst. of Toxicology and Chemotherapy, German Cancer Research Center, Heidelberg, Germany |
1988 Lecturer, Cancer Institute, Sun Yat-Sen University, GuangZhou, P.R. China |
1988 - 1992 Guest Scientist, Inst. of Toxicology and Chemotherapy, German Cancer Research Center, Heidelberg, Germany |
01/1992 - 12/1995 Postdoctoral Research Fellow, Dana-Farber Institute, Harvard Medical School, MA, Division of Cancer Pharmacology, Boston |
1992 - 1995 Postdoctoral Research Fellow, Dana-Farber Institute, Division of Cancer Pharmacology, Harvard Medical School, Boston, MA |
01/1995 - 12/2000 Assistant Professor, Department of Molecular Biology, Cleveland Clinic Foundation, Lerner Research Institute, Cleveland, OH |
1995 - 2000 Assistant Professor, Department of Molecular Biology, Cleveland Clinic Foundation, Lerner Research Institute, Cleveland, OH |
09/01/2000 - Present Associate Professor, Department of Radiation Oncology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153 |
09/2000 - Present Associate Professor, Department of Radiation Oncology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153 |
07/01/2003 - Present Associate Professor, Department of Radiation Oncology, Loyola University of Chicago, Maywood, IL 60153 |
07/2003 - Present Associate Professor, Department of Radiation Oncology, Loyola University of Chicago, Maywood, IL 60153 |
02/01/2004 - Present Associate Professor, Department of Pharmacology and Experimental Therapeutics, Loyola University of Chicago, Maywood, IL 60153 |
02/2004 - Present Associate Professor, Department of Pharmacology and Experimental Therapeutics, Loyola University of Chicago, Maywood, IL 60153 |
03/01/2006 - Present Professor, Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226 |
03/2006 - Present Professor, Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226 |
EDUCATIONAL ADMINISTRATIVE APPOINTMENTS: |
09/01/2000 - Present Member of Molecular Biology Program, Graduate School, Loyola University of Chicago, Maywood, IL 60153 |
09/01/2000 - Present Member of Molecular and Cellular Biochemistry Program, Graduate School, Loyola University of Chicago, Maywood, IL 60153 |
09/2000 - Present Member of Molecular and Cellular Biochemistry Program, Graduate School, Loyola University of Chicago, Maywood, IL 60153 |
09/2000 - Present Member of Molecular Biology Program, Graduate School, Loyola University of Chicago, Maywood, IL 60153 |
AWARDS AND HONORS: |
1988 - 1992 Guest Scientist Scholarship, German Cancer Research Center (DKFZ) in Institute of Toxicology and Chemotherapy, German Cancer Research Center, Heidelberg, Germany |
1988 - 1992 Guest Scientist Scholarship, German Cancer Research Center (DKFZ) in Institute of Toxicology and Chemotherapy, German Cancer Research Center, Heidelberg, Germany |
1989 - Present Gerhard-Domagk Award |
1989 Gerhard-Domagk Award |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
1997 - Present New York Academy of Sciences (Active Member) |
1997 - Present New York Academy of Sciences (Active Member) |
2012 - Present Federation of American Societies for Experimental Biology (Member) |
2012 - Present American Society for Pharmacology and Experimental Therapeutics (Member) |
2012 - Present American Society for Biochemistry and Molecular Biology (Member) |
2012 - Present American Association for Cancer Research (Active Member) |
American Society for Pharmacology and Experimental Therapeutics (Member) |
American Association for Cancer Research (Active Member) |
Federation of American Societies for Experimental Biology (Member) |
American Society for Biochemistry and Molecular Biology (Member) |
EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS: |
Editorship |
2001 - Present Frontier in Biosciences |
2001 - Present Frontier in Biosciences |
2006 - 2010 International Journal of Cancer Research |
2006 - 2010 International Journal of Cancer Research |
2010 - Present American Journal of Cancer Research |
2010 - Present American Journal of Cancer Research |
Journal Review |
2012 - Present Cancer Res., Blood, Int. J. Cancer, Oncogene, BBRC, Carcinogenesis, FASEB J., BBA, Int J Biol Sci |
Cancer Res., Blood, Int. J. Cancer, Oncogene, BBRC, Carcinogenesis, FASEB J., BBA, Int J Biol Sci |
LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
01/2000 - 12/2006 Member, Recruiting Committee for Cancer Center, Department of Radiation Oncology; Department of Urology, and Program of Hematology, and Skin Cancer Program, Loyola University |
01/2000 - 12/2002 Co-Chair, Research Safety Committee, Hines VA Medical Center, Loyola University |
2000 - 2006 Member, Recruiting Committee for Cancer Center, Department of Radiation Oncology; Department of Urology, and Program of Hematology, and Skin Cancer Program, Loyola University |
2000 - 2002 Co-Chair, Research Safety Committee, Hines VA Medical Center, Loyola University |
01/2002 - Present Member, Graduate admission committee, Molecular Biology Program, Loyola University of Chicago |
01/2002 - 12/2004 Member, Research Safety Committee, Hines VA Medical Center |
2002 - Present Member, Graduate admission committee, Molecular Biology Program, Loyola University of Chicago |
2002 - 2004 Member, Research Safety Committee, Hines VA Medical Center |
01/2003 - 12/2006 Member, Faculty recruiting committee, Department of Pharmacology, Loyola University |
2003 - 2006 Member, Faculty recruiting committee, Department of Pharmacology, Loyola University |
01/2004 - Present Member, Research & Development Committee, Research Services, Hines VA Medical Center |
01/2004 - 12/2006 Member, Hematology/Oncology Grand Review Panel, Cancer Center, Loyola University of Chicago |
01/2004 - 12/2006 Member, Core Curriculum Oversight Committee, Loyola Graduate School, Loyola University of Chicago |
01/2004 - Present Member, Graduate admission committee, Department of Pharmacology, Loyola |
2004 - 2006 Member, Core Curriculum Oversight Committee, Loyola Graduate School, Loyola University of Chicago |
2004 - Present Member, Research & Development Committee, Research Services, Hines VA Medical Center |
2004 - 2006 Member, Hematology/Oncology Grand Review Panel, Cancer Center, Loyola University of Chicago |
2004 - Present Member, Graduate admission committee, Department of Pharmacology, Loyola |
01/2006 - Present Member, PhD candidate Recruiting, Graduate School, Medical College of Wisconsin |
01/2006 - Present Member, Blood Institute of Wisconsin Recruiting, Medical College of Wisconsin |
01/2006 - Present Member, Department of Biochemistry recruiting Committee, Medical College of Wisconsin |
01/2006 - Present Member, Department of Medicine/Division of Endocrinology recruiting, Medical College of Wisconsin |
01/2006 - Present Member, Cancer Center Open House, Medical College of Wisconsin |
01/2006 - Present Member, Department of Pharmacology recruiting Committee, Medical College of Wisconsin |
2006 - Present Member, Department of Medicine/Division of Endocrinology recruiting, Medical College of Wisconsin |
2006 - Present Member, Blood Institute of Wisconsin Recruiting, Medical College of Wisconsin |
2006 - Present Member, Cancer Center Open House, Medical College of Wisconsin |
2006 - Present Member, Department of Pharmacology recruiting Committee, Medical College of Wisconsin |
2006 - Present Member, PhD candidate Recruiting, Graduate School, Medical College of Wisconsin |
2006 - Present Member, Department of Biochemistry recruiting Committee, Medical College of Wisconsin |
01/2007 - 12/2008 Member, Curriculum and Programs Committee, Graduate School, Medical College of Wisconsin |
01/2007 - Present Recruiting Director, Department of Pharmacology and Toxicology, Medical College of Wisconsin |
2007 - 2008 Member, Curriculum and Programs Committee, Graduate School, Medical College of Wisconsin |
2007 - Present Recruiting Director, Department of Pharmacology and Toxicology, Medical College of Wisconsin |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
International |
Symposium for Cancer Drug Resistance, Kiel, Germany, 1990 |
Annual German Cancer Research Meeting, Heidelberg, Germany, 1991 |
International Conference of Chemotherapy, Berlin, Germany, 1991 |
12th World Congress on Advances in Oncology, Crete, Greece, 2007 |
Symposium for Cancer Drug Resistance, Kiel, Germany, 1990 |
Annual German Cancer Research Meeting, Heidelberg, Germany, 1991 |
12th World Congress on Advances in Oncology, Crete, Greece, 2007 |
International Conference of Chemotherapy, Berlin, Germany, 1991 |
National |
Isis Pharmaceutical, CA, 2000 |
Department of Pharmacology, George Washington University, Washington, DC, 2000 |
Tulane Cancer Center, Tulane University, New Orleans, LA, 2005 |
Department of Biochemistry, Virginia Commonwealth University (VCU), Richmond, Virginia, 2005 |
Department of Pediatrics and Cancer Center, University of Louisville, 2005 |
Molecular Biology, Mayo Clinic Arizona, Scottsdale, AZ, 2005 |
Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, 2005 |
Isis Pharmaceutical, CA, 2000 |
Department of Pharmacology, George Washington University, Washington, DC, 2000 |
Tulane Cancer Center, Tulane University, New Orleans, LA, 2005 |
Department of Biochemistry, Virginia Commonwealth University (VCU), Richmond, Virginia, 2005 |
Department of Pediatrics and Cancer Center, University of Louisville, 2005 |
Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, 2005 |
Molecular Biology, Mayo Clinic Arizona, Scottsdale, AZ, 2005 |
Regional |
Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH, 2000 |
Department of Radiation Oncology, Washington University in St. Louis, MO, 2000 |
Cancer Center, Loyola University Medical Center, Chicago, IL, 2000 |
Molecular Biology Program, Loyola University of Chicago, 2001 |
Program in Molecular and Cellular Biochemistry, Loyola University of Chicago, 2002 |
Department of Pharmacology and Experimental Therapeutics, Loyola University of Chicago, 2003 |
Program in Molecular Biology, Loyola University of Chicago, 2004 |
Department of Radiation Oncology, Loyola University of Chicago, 2005 |
Barbara Ann Karmanos Cancer Institute, Detroit, MI, 2006 |
Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH, 2000 |
Department of Radiation Oncology, Washington University in St. Louis, MO, 2000 |
Cancer Center, Loyola University Medical Center, Chicago, IL, 2000 |
Molecular Biology Program, Loyola University of Chicago, 2001 |
Program in Molecular and Cellular Biochemistry, Loyola University of Chicago, 2002 |
Department of Pharmacology and Experimental Therapeutics, Loyola University of Chicago, 2003 |
Program in Molecular Biology, Loyola University of Chicago, 2004 |
Department of Radiation Oncology, Loyola University of Chicago, 2005 |
Barbara Ann Karmanos Cancer Institute, Detroit, MI, 2006 |
Local |
Department of Biology, Toledo University, Toledo, OH, 2000 |
Medical College of Wisconsin, Department of Pharmacology, Milwaukee, WI, 2005 |
Department of Biology, Toledo University, Toledo, OH, 2000 |
Medical College of Wisconsin, Department of Pharmacology, Milwaukee, WI, 2005 |
MCW TEACHING ACTIVITIES: |
Medical Student Education |
01/01/2007 - 05/01/2007 Present Medical Pharmacology (Small group) |
2007 - Present Medical Pharmacology (Small group) |
01/01/2008 - 05/01/2008 Present Pharmacology, Herbs and Supplemental Medicine (lecture) |
2008 - Present Pharmacology, Herbs and Supplemental Medicine (lecture) |
Graduate Student Education |
01/01/2006 - 12/31/2011 Present Nuclear Receptors-Mechanisms of Cellular Signaling (Course #16250) and the Course Director (2011) |
2006 - Present Nuclear Receptors-Mechanisms of Cellular Signaling (Course #16250) and the Course Director (2011) |
01/01/2008 - 12/31/2012 Present MAPKs and PI3Ks-Cellular Signal Transduction/ (Course #07224) |
01/01/2008 - 12/31/2012 Present Analytic Methods in Pharmacology and Toxicology-Protein-protein interaction (Course #07243) |
2008 - Present MAPKs and PI3Ks-Cellular Signal Transduction/ (Course #07224) |
2008 - Present Analytic Methods in Pharmacology and Toxicology-Protein-protein interaction (Course #07243) |
01/01/2010 - 12/31/2012 Present Cancer Genetics-Ras/MAPK signaling in cancer (Course #05251) |
2010 - Present Cancer Genetics-Ras/MAPK signaling in cancer (Course #05251) |
EXTRAMURAL TEACHING: |
Medical Student Education |
01/01/2001 - 10/31/2012 Present Department of Radiation Oncology, Loyola University of Chicago, Signal transduction, Genomic Instability |
2001 - Present Department of Radiation Oncology, Loyola University of Chicago, Signal transduction, Genomic Instability |
01/01/2002 - 12/31/2002 Department of Radiation Oncology, Loyola University of Chicago, MAPK and DNA repair, MAPK and Radiation response |
2002 Department of Radiation Oncology, Loyola University of Chicago, MAPK and DNA repair, MAPK and Radiation response |
01/01/2004 - 12/31/2005 Department of Radiation Oncology, Loyola University of Chicago, 1) Apoptosis & Radiation 2) Cell Kinetics (Radiobiology Basis) |
2004 - 2005 Department of Radiation Oncology, Loyola University of Chicago, 1) Apoptosis & Radiation 2) Cell Kinetics (Radiobiology Basis) |
Graduate Student Education |
01/2001 - 12/2001 Loyola University of Chicago, Signal transduction Special Core Curriculum (#MIIM502817) |
01/2001 - 05/2003 Loyola University of Chicago, Oncogenesis Molecular Biology Program (#MB10590) |
01/2001 - 05/2002 Present Loyola University of Chicago, MAPK signaling Physiology (#471), Molecular Biology (#527), CBNA (#441) |
2001 - Present Loyola University of Chicago, MAPK signaling Physiology (#471), Molecular Biology (#527), CBNA (#441) |
2001 - 2003 Loyola University of Chicago, Oncogenesis Molecular Biology Program (#MB10590) |
2001 Loyola University of Chicago, Signal transduction Special Core Curriculum (#MIIM502817) |
01/2002 - 05/2003 Loyola University of Chicago, DNA repair Molecular Biology (#526) |
2002 Loyola University of Chicago, DNA repair Molecular Biology (#526) |
01/2005 - 05/2004 Present Loyola University of Chicago, Nuclear receptors Pharmacology (#409) |
2005 - Present Loyola University of Chicago, Nuclear receptors Pharmacology (#409) |
MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Graduate Students |
PhD Students Advised |
2001 - 2003 Rocky Pramanik, Science Research, Co Scientist, Medical College of Wisconsin |
2002 Zan Huang, Molecular Biology Rotating, Medical College of Wisconsin |
2003 Viral Brahmbhatt, CBNA/Biochemistry Rotating, Medical College of Wisconsin |
2003 - 2005 Jun Tang, University of Chicago Research Asso, Medical College of Wisconsin |
2004 Sreevidya Sivaswamy, Biochemistry Rotating, Medical College of Wisconsin |
2005 - Present Mathew Loesch, Pharmacology Mentor, Medical College of Wisconsin |
2007 Amy Sasman, Pharmacology Rotating, Medical College of Wisconsin |
2007 Elizabeth Ntantie, IDP/Graduate School Rotating, Medical College of Wisconsin |
2008 Dusanka Vesic, IDP/Graduate School Rotating, Medical College of Wisconsin |
2008 Nicole Pohl, Pharmacology/MCW Mentor, Medical College of Wisconsin |
2008 Kristin Aicher, IDP/Graduate School Rotating, Medical College of Wisconsin |
2008 Adrinne Lepp, IDP/Graduate School Rotating, Medical College of Wisconsin |
2008 Justin Reitsman, IDP/Graduate School Rotating, Medical College of Wisconsin |
2009 Brandon-Rindfleisch, IDP/Graduate School Rotating, Medical College of Wisconsin |
2009 Mathew Loesch, Pharmacology/MCW Mentor, Medical College of Wisconsin |
2010 Yusuke Kobayashi, Yokohama City Co-Mentor University, Japan, Medical College of Wisconsin |
2010 Mansi Karkhanis, IDP/Graduate School Rotating, Medical College of Wisconsin |
Yalin Li, MCW Postdoc fellow, Medical College of Wisconsin |
Songwang Hou, MCW Postdoc associate, Medical College of Wisconsin |
Huiying Zhi, MCW Postdoc fellow, Medical College of Wisconsin |
MA Students Advised |
2002 - Present Zan Huang, Molecular Biology Rotating, MCW |
2003 - 2005 Jun Tang, University of Chicago Research Asso, MCW |
2003 - Present Viral Brahmbhatt, CBNA/Biochemistry Rotating, MCW |
2004 - Present Sreevidya Sivaswamy, Biochemistry Rotating, MCW |
2007 - Present Elizabeth Ntantie, IDP/Graduate School Rotating, MCW |
2008 - Present Kristin Aicher, IDP/Graduate School Rotating, MCW |
2008 - Present Adrinne Lepp, IDP/Graduate School Rotating, MCW |
2008 - Present Dusanka Vesic, IDP/Graduate School Rotating, MCW |
2009 - Present Brandon-Rindfleisch, IDP/Graduate School Rotating, MCW |
Huiying Zhi, Postdoc fellow, MCW |
Songwang Hou, Postdoc associate, MCW |
Yalin Li, Postdoc fellow, MCW |
MS Students Advised |
2002 - 2003 Stanley J. Borowicz, CBNA/Biochemistry Co-Mentor, Medical College of Wisconsin |
2003 Stanley J. Borowicz, CBNA/Biochemistry Co-Mentor Loyola, Medical College of Wisconsin |
2004 - Present Nicole Pohl, Molecular Biology Mentor, Medical College of Wisconsin |
2004 Melanie Weytkow, Pharmacology Summer, Medical College of Wisconsin |
2005 Amrita Dhupelia, Pharmacology Summer, Medical College of Wisconsin |
2011 Adrienne Lepp, Pharmacology/MCW Mentor, Medical College of Wisconsin |
Adrienne Lepp, MCW Student, Medical College of Wisconsin |
Xiaomei Qi, Medical College of Wisconsin |
PhD Committees |
2002 - 2005 Haixi Miao, Supervisor, Lucio Miller, Medical College of Wisconsin |
2004 - 2005 Qinping Li, Nanjing Medical Professor in China, Medical College of Wisconsin |
2004 - 2009 Nicole Pohl, Supervisor, Dr. Guan Chen, Medical College of Wisconsin |
2004 - 2005 Qinping Li, Nanjing Medical Professor in China, Medical College of Wisconsin |
2005 - 2009 Mathew Loesch, Supervisor, Dr. Guan Chen, Medical College of Wisconsin |
2008 - 2010 Tracy Berg, Supervisor, Carol William (Pharmacology), Medical College of Wisconsin |
2008 - 2009 Hong Guan, Supervisor, Robert Descheins, Biochemistry, Medical College of Wisconsin |
2009 Nathan Schuld, IDP/Graduate School Rotating, Medical College of Wisconsin |
MS Committees |
2003 - 2005 Stanley Borowicz, Mater, Supervisor, Dr. Guan Chen, Medical College of Wisconsin |
2009 - Present Adam Gastonguy, (Pharmacology), Supervisor, Carol William, Medical College of Wisconsin |
2009 - Present Jaclyn Porath, (Blood Research Inst), Gil White, Medical College of Wisconsin |
2010 - Present Adrienne Lepp, (Pharmacology), Supervisor, Guan Chen, Medical College of Wisconsin |
2010 Benjamin Tourdot, (Blood Research Inst), Debra Newman, Medical College of Wisconsin |
2010 Anna Alexanian, (Microbiology), Supervisor, Andrey Sorokin, Medical College of Wisconsin |
2011 - Present Elizabeth Ntantie, (Pharmacology), Supervisor, Carol William, Medical College of Wisconsin |
MA Committees |
2009 - Present Nathan Schuld, IDP/Graduate School Rotating, Medical College of Wisconsin |
MPh Students Advised |
2010 Jessica Wilson, Medical School Rotating, Medical College of Wisconsin |
Postdoctoral Researchers |
2000 - 2001 Jin-Tang Wang, Canada Postdoc, Medical College of Wisconsin |
2001 - 2002 Zan Huang, University of Chicago Postdoc, Medical College of Wisconsin |
EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Graduate Students |
PhD Committees |
2000 - 2006 Haixi Miao, candidate for Biochemistry and Cell Biology Program, (Advisor: Lucia Miller), Loyola University of Chicago |
01/2001 - 06/2003 Student Name 3, Dissertation title, UW-Milwaukee |
2002 - 2004 Anisha Dcosta, candidate for Molecular Biology Program (Advisor: Mitch Denning), Loyola University of Chicago |
2004 - Present Charles Gunawan, candidate for Pharmacology (Advisor: Tarun B. Patel) |
2004 Vigneshwran Krishnamoorthy, candidate for Department of Cellular and Molecular Physiology (Advisor: Jody L. Martin), Loyola University of Chicago |
2005 Matew Loesch, candidate for Department of Pharmacology (Advisor: Guan Chen), Loyola University of Chicago |
2005 Rakesh Singh, candidate for Department of Pharmacology (Advisor: Tarun Patel), Loyola University of Chicago |
2005 Anita Jerome, candidate for Molecular Biology Program (Adviser: Mitch Denning), Loyola University of Chicago |
2005 Nicole Phol, candidate for Molecular Biology Program (Advisor: Guan Chen), Loyola University of Chicago |
MS Committees |
2001 - 2003 Stanley Borowicz, a Master candidate for CBNA (Advisors: Guan Chen & Richard Schultz), Loyola University of Chicago |
2003 - Present Yuanbin Chen, candidate for Molecular Biology Program (Advisor: Yan Su), Loyola University of Chicago |
2006 Vigneshwran Krishnamoorthy, Program in Cellular and Molecular Physiology, Loyola University of Chicago |
MA Committees |
GRANT REVIEW/STUDY SECTION: |
01/01/2001 - 12/31/2001 Ohio Cancer Association, Florida Cancer Association
|
01/01/2001 - 12/31/2001 Present Ohio Cancer Association, Florida Cancer Association |
01/01/2006 - 12/31/2006 Ad hoc scientific reviewer for DOD, Breast Cancer Research Program (CET-4, Clinical & Experimental Therapeutics #4 panel) |
01/01/2006 - 10/12/2012 Cancer Center, Medical College of Wisconsin (MCW) |
01/01/2007 - 12/31/2007 Ad hoc scientific reviewer for NIH MONC study section (Molecular Oncogenesis), ARRA RC1 Challenge Grant (ZRG1 OTC-K 58) |
01/01/2007 - 10/12/2012 Ad hoc scientific reviewer for Special Research Program (SFB, Cell Proliferation and Cell Death in Tumors), Austrian Science Foundation (FWF), The Wellcome- Trust Foundation, England; Health Research Board, Ireland |
01/01/2008 - 12/31/2008 Ad hoc scientific reviewer for Susan G. Komen for the Cure (TT-1, Target Therapeutics) |
01/01/2008 - 10/12/2012 VA, Ad hoc Scientific reviewer for Oncology Study Section and Career Development Pane |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Hou, S., Padmanaban, S., Qi, X., Lepp, A., Mirza, S. P., and Chen, G. p38gamma MAPK signals through phosphorylating its phosphatase PTPH1 in regulating Ras oncogenesis and stress response. J Biol Chem 2012,287: 27895-27950 |
2. Yusuke, Kobayashi, Xiaomei Qi, and Chen, G. MK2 regulates Ras oncogenesis through stimulating ROS production. Gene & Cancer, 2012 in press |
3. Qi, X., Zhi, H., Lepp, A., Wang, P., Huang, J., Basir, Z., Chitambar, C. R., Myers, C. R., and Chen, G. p38gamma mitogen-activated protein kinase (MAPK) confers breast cancer hormone sensitivity by switching estrogen receptor (ER) signaling from the classical to the non-classical pathway via stimulating ER phosphorylation and c-Jun transcription. J Biol Chem 2012, 287: 14681-14691 |
4. Zhi HY, Hou SW, Li RS, Basir Z, Xiang Q, Szabo A, Chen G. PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization. Oncogene. 2011 Apr 07;30(14):1706-15. PMCID: PMC3072445 |
5. Qi, X., Hou, S., Lepp, A., Li, R., Basir, Z., Lou, Z., and Chen, G. Phosphorylation and stabilization of topoisomerase II by p38 MAPK sensitize breast cancer cells to its poisons. J Biol Chem 2011, 286: 35883-35890 |
6. Zhi, H., Hou, S., Li, R., Basir, Z., Xiang, Q., Szabo, A., Chen, G. PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization. Oncogene, in press 2011, (this paper was highlighted by TIS, known as the Target Intelligence Service.) https://www.targetintelligenceservice.com/main/public/case.jsp?report_id=43816 |
7. Hou, S., Lepp, A., Chen, G. (2010) p38gamma MAP kinase (review). UCSD-Nature Molecular Pages 1September 2010 / doi:10.1038/mp.a001720.01 |
8. Hou, S., Zhi, H., Pohl, N., Loesch, M., Qi, X., Li, R., Basir, Z., and Chen, G. (2010) PTPH1 dephosphorylates and cooperate with p38gamma MAPK to increase Ras oncogenesis through PDZ-mediated interaction. Cancer Res. 70: 2901-2910 |
9. Hou SW, Zhi HY, Pohl N, Loesch M, Qi XM, Li RS, Basir Z, Chen G. PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction. Cancer Res. 2010 Apr 01;70(7):2901-10. PMCID: PMC2848905 |
10. Loesch, M., Zhi, H., Hou, S., Qi, X., Li, R., Basir, Z., Iftner, T., Cuenda, A., and Chen, G. (2010) p38gamma MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9. 2010, J. Biol. Chem. 285: 15149-15158 |
11. Loesch, M., Chen, G. The p38gamma MAPK stress pathway as a tumor suppressor or more? Front. Biosci., 2008, 13: 3581-3593 (review). |
12. Li QP, Qi X, Pramanik R, Pohl NM, Loesch M, Chen G. Stress-induced c-Jun-dependent Vitamin D receptor (VDR) activation dissects the non-classical VDR pathway from the classical VDR activity. J Biol Chem. 2007 Jan 19;282(3):1544-51. |
13. Qi X, Pohl NM, Loesch M, Hou S, Li R, Qin JZ, Cuenda A, Chen G. p38alpha antagonizes p38gamma activity through c-Jun-dependent ubiquitin-proteasome pathways in regulating Ras transformation and stress response. J Biol Chem. 2007 Oct 26;282(43):31398-408. |
14. Qi X, Tang J, Loesch M, Pohl N, Alkan S, Chen G. p38gamma mitogen-activated protein kinase integrates signaling crosstalk between Ras and estrogen receptor to increase breast cancer invasion. Cancer Res. 2006 Aug 01;66(15):7540-7. PMCID: PMC2174269 |
15. Hou S, Suresh PS, Qi X, Lepp A, Mirza SP, Chen G. p38γ Mitogen-activated protein kinase signals through phosphorylating its phosphatase PTPH1 in regulating ras protein oncogenesis and stress response. J Biol Chem. 2012 Aug 10;287(33):27895-905. PMCID: PMC3431700 |
16. Hou S, Suresh PS, Qi X, Lepp A, Mirza SP, Chen G. p38γ Mitogen-activated protein kinase signals through phosphorylating its phosphatase PTPH1 in regulating ras protein oncogenesis and stress response. J Biol Chem. 2012 Aug 10;287(33):27895-905. PMCID: PMC3431700 |
17. Qi X, Zhi H, Lepp A, Wang P, Huang J, Basir Z, Chitambar CR, Myers CR, Chen G. p38γ mitogen-activated protein kinase (MAPK) confers breast cancer hormone sensitivity by switching estrogen receptor (ER) signaling from classical to nonclassical pathway via stimulating ER phosphorylation and c-Jun transcription. J Biol Chem. 2012 Apr 27;287(18):14681-91. PMCID: PMC3340246 |
18. Zhi HY, Hou SW, Li RS, Basir Z, Xiang Q, Szabo A, Chen G. PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization. Oncogene. 2011 Apr 07;30(14):1706-15. PMCID: PMC3072445 |
19. Loesch M, Zhi HY, Hou SW, Qi XM, Li RS, Basir Z, Iftner T, Cuenda A, Chen G. p38gamma MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9. J Biol Chem. 2010 May 14;285(20):15149-15158. PMCID: PMC2865276 |
20. Hou SW, Zhi HY, Pohl N, Loesch M, Qi XM, Li RS, Basir Z, Chen G. PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction. Cancer Res. 2010 Apr 01;70(7):2901-10. PMCID: PMC2848905 |
21. Qi XM, Wang F, Mortensen M, Wertz R, Chen G. Targeting an oncogenic kinase/phosphatase signaling network for cancer therapy. Acta Pharm Sin B. 2018 Jul;8(4):511-517. PMCID: PMC6089844 |
22. Yin N, Lepp A, Ji Y, Mortensen M, Hou S, Qi XM, Myers CR, Chen G. The K-Ras effector p38γ MAPK confers intrinsic resistance to tyrosine kinase inhibitors by stimulating <i>EGFR</i> transcription and EGFR dephosphorylation. J Biol Chem. 2017 Sep 08;292(36):15070-15079. PMCID: PMC5592682 |
23. Chen G, Templeton D, Suttle DP, Stacey DW. Ras stimulates DNA topoisomerase II alpha through MEK: a link between oncogenic signaling and a therapeutic target. Oncogene. 1999 Nov 25;18(50):7149-60. |
24. Chen G, Teicher BA, Frei E 3rd. Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype. Cancer Biochem Biophys. 1998 Jun;16(1-2):139-55. |
25. Chen G, Shu J, Stacey DW. Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide. Oncogene. 1997 Oct 02;15(14):1643-51. |
26. Chen G, Teicher BA, Frei E 3rd. Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells. Anticancer Res. 1996;16(6B):3499-505. |
27. Chen G, Hutter KJ, Zeller WJ. Positive correlation between cellular glutathione and acquired cisplatin resistance in human ovarian cancer cells. Cell Biol Toxicol. 1995 Oct;11(5):273-81. |
28. Chen G, Waxman DJ. Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells. Biochem Pharmacol. 1995 May 26;49(11):1691-701. |
29. Chen G, Waxman DJ. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. Biochem Pharmacol. 1994 Mar 15;47(6):1079-87. |
30. Chen G, Ramachandran C, Krishan A. Thaliblastine, a plant alkaloid, circumvents multidrug resistance by direct binding to P-glycoprotein. Cancer Res. 1993 Jun 01;53(11):2544-7. |
31. Chen G, Zeller WJ. Reversal of acquired cisplatin resistance by nicotinamide in vitro and in vivo. Cancer Chemother Pharmacol. 1993;33(2):157-62. |
32. Chen G, Zeller WJ. Multiple effects of 3-aminobenzamide on DNA damage induced by cisplatin (DDP) in DDP-sensitive and -resistant rat ovarian tumor cell lines. Cancer Lett. 1992 Oct 30;67(1):27-33. |
33. Chen G, Zeller WJ. Increased poly(ADP-ribose) formation in cisplatin-resistant rat ovarian tumor cells. Anticancer Res. 1994;14(4A):1461-7. |
34. Bürkle A, Chen G, Küpper JH, Grube K, Zeller WJ. Increased poly(ADP-ribosyl)ation in intact cells by cisplatin treatment. Carcinogenesis. 1993 Apr;14(4):559-61. |
35. Chen G, Todorov DK, Zeller WJ. Antitumor activity of thaliblastine (NSC-68075) in experimental ovarian tumor cell lines sensitive and resistant to cisplatin. Cancer Lett. 1992 Feb 29;62(2):173-7. |
36. Chen G, Zeller WJ. Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links. Anticancer Res. 1991;11(6):2231-7. |
37. Zeller WJ, Frühauf S, Chen G, Keppler BK, Frei E, Kaufmann M. Chemoresistance in rat ovarian tumours. Eur J Cancer. 1991;27(1):62-7. |
38. Chen G, Zeller WJ. Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo. Cancer Chemother Pharmacol. 1990;26(1):37-41. |
39. Zeller WJ, Frühauf S, Chen G, Eisenbrand G, Lijinsky W. Biological activity of hydroxylated chloroethylnitrosoureas. Cancer Res. 1989 Jun 15;49(12):3267-70. |
40. Chen G, Li W. Editorial Preface for Targeted Cancer Therapy Acta Pharmaceutica Sinica B. July 2018;8(4):501-502. |
41. Stacey DW, Hitomi M, Chen G. Influence of cell cycle and oncogene activity upon topoisomerase IIalpha expression and drug toxicity. Mol Cell Biol. 2000 Dec;20(24):9127-37. PMCID: PMC102171 |
42. Chen G, Baechle A, Nevins TD, Oh S, Harmon C, Stacey DW. Protection against cyclophosphamide-induced alopecia and inhibition of mammary tumor growth by topical 1,25-dihydroxyvitamin D3 in mice. Int J Cancer. 1998 Jan 19;75(2):303-9. |
43. Teicher BA, Holden SA, Ara G, Chen G. Transforming growth factor-beta in in vivo resistance. Cancer Chemother Pharmacol. 1996;37(6):601-9. |
44. Chen G, Zeller WJ, Todorov DK. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin. Anticancer Res. 1993;13(5A):1269-75. |
45. Chen G, Zeller WJ. Investigations on synergistic effects of BSO and 3AB for the reversal of cisplatin resistance Tumor Diagnostik und Therapie. 1991;12(6):226-229. |
46. Chen G, Hutter KJ, Bullerdiek J, Zeller WJ. Karyotypic change from heteroploidy to near diploidy associated with development of cisplatin resistance in a rat ovarian tumour cell line. J Cancer Res Clin Oncol. 1991;117(6):539-42. |
47. Chen G, Zeller WJ. In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line. J Cancer Res Clin Oncol. 1990;116(5):443-7. |
48. Chen G, Frei E, Zeller WJ. Determination of intracellular reduced glutathione and glutathione related enzyme activities in cisplatin-sensitive and resistant experimental ovarian carcinoma cell lines. Cancer Lett. 1989 Aug;46(3):207-11. |
49. Chen G, Hitomi M. Dissociation of CDK2 from cyclin A in response to the topoisomerase II inhibitor etoposide in v-src-transformed but not normal NIH 3T3 cells. Exp Cell Res. 1999 Jun 15;249(2):327-36. |
50. Chen G, Waxman DJ. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance. J Pharmacol Exp Ther. 1995 Sep;274(3):1271-7. |
51. Chen G, Pan QC. Potentiation of the antitumor activity of cisplatin in mice by 3-aminobenzamide and nicotinamide. Cancer Chemother Pharmacol. 1988;22(4):303-7. |
52. Chen G, Oh S, Monia BP, Stacey DW. Antisense oligonucleotides demonstrate a dominant role of c-Ki-RAS proteins in regulating the proliferation of diploid human fibroblasts. J Biol Chem. 1996 Nov 08;271(45):28259-65. |
53. Chen G, Zeller WJ. Effects of thaliblastine on cytotoxicity and DNA damage in drug-sensitive and -resistant rat ovarian tumor cells treated with cisplatin. Anticancer Res. 1993;13(1):219-23. |
54. Chang TK, Chen G, Waxman DJ. Modulation of thiotepa antitumor activity in vivo by alteration of liver cytochrome P450-catalyzed drug metabolism. J Pharmacol Exp Ther. 1995 Jul;274(1):270-5. |
55. Chen G, Li W. Editorial Preface for Targeted Cancer Therapy. Acta Pharm Sin B. 2018 Jul;8(4):501-502. PMCID: PMC6090083 |
56. Fang Wang, Xiao-Mei Qi, Ryan Wertz, Matthew Mortensen, Catherine Hagen, John Evans, Yuri Sheinin, Michael James, Pengyuan Liu, Susan Tsai, James Thomas, Alexander Mackinnon, Michael Dwinell, Charles R Myers, Ramon Bartrons, Liwu Fu, Guan Chen. p38gamma MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis Cancer Research. Wang F, Qi XM, Wertz R, et al. p38gamma MAPK is essential for aerobic glycolysis and pancreatic tumorigenesis [published online ahead of print, 2020 Jun 24]. Cancer Res. 2020;canre. |
57. Wang F, Qi XM, Wertz R, Mortensen M, Hagen C, Evans J, Sheinin Y, James M, Liu P, Tsai S, Thomas J, Mackinnon A, Dwinell M, Myers CR, Bartrons Bach R, Fu L, Chen G. p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis. Cancer Res. 2020 Aug 15;80(16):3251-3264. PMCID: PMC9358694 |
58. Chen G, Pan QC. [Enhancement of the antitumor activity of bleomycin A5 by 3-aminobenzamide in vitro and in vivo]. Yao Xue Xue Bao. 1985 May;20(5):331-3. |
59. Qin JZ, Xin H, Qi XM, Chen G. Isoform-specific and cell/tissue-dependent effects of p38 MAPKs in regulating inflammation and inflammation-associated oncogenesis. Front Biosci (Landmark Ed). 2022 Jan 18;27(1):31. |
60. Qi XM, Chen G. p38γ MAPK Inflammatory and Metabolic Signaling in Physiology and Disease. Cells. 2023 Jun 21;12(13). PMCID: PMC10341180 |